Risk Manag Healthc Policy. 2018 Dec 03;11:243-250. doi: 10.2147/RMHP.S176517. eCollection 2018.
Is methicillin-resistant .
Risk management and healthcare policy
Aparajita Chatterjee, Shipra Rai, Vasudeva Guddattu, Chiranjay Mukhopadhyay, Kavitha Saravu
Affiliations
Affiliations
- Department of Medicine, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India, [email protected], [email protected].
- Department of Statistics, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India.
- Department of Microbiology, Kasturba Medical College Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India.
- Manipal McGill Center for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India, [email protected].
PMID: 30584380
PMCID: PMC6284536 DOI: 10.2147/RMHP.S176517
Abstract
PURPOSE: To determine morbidity and mortality of methicillin-resistant
METHODS: A cohort study among hospitalized adult patients with culture proven MRSA or MSSA monoinfection were recruited in a tertiary referral center in South India from November 2011 to December 2012.
RESULTS: Of total 551 subjects, 284 (52%) had MRSA and 267 (48%) MSSA infection. A total of 184 (65%) subjects had health care-associated MRSA (HA-MRSA) and 100 (35%) community-associated MRSA (CA-MRSA). Chronic kidney disease and recent antibiotic use had significant association with MRSA. MRSA patients had significant respiratory infection (OR 2.24 [1.04, 5.16]) and bacteremia (OR 2.24 [10.40, 5.16]), relative to MSSA. MSSA group had better survival function compared to MRSA group (
CONCLUSION: MRSA imposes a huge burden in Indian scenario and HA-MRSA remains the main culprit. Patients with history of chronic kidney disease and recent use of antibiotics were found to be at a higher risk. Patients with MRSA infections tend to have poorer outcomes in terms of longer hospital stay, greater complications, and mortality.
Keywords: India; Staphylococcus aureus; impact; methicillin-resistant Staphylococcus aureus; morbidity; mortality; outcome; prognosis; risk factors
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
- Clin Infect Dis. 2000 Feb;30(2):368-73 - PubMed
- Arch Intern Med. 2002 Oct 28;162(19):2229-35 - PubMed
- Clin Infect Dis. 2003 Jan 1;36(1):53-9 - PubMed
- Clin Infect Dis. 2003 Mar 1;36(5):592-8 - PubMed
- Infect Control Hosp Epidemiol. 1992 Oct;13(10):587-93 - PubMed
- Am J Infect Control. 2004 Dec;32(8):470-85 - PubMed
- N Engl J Med. 2006 Aug 17;355(7):666-74 - PubMed
- Infect Control Hosp Epidemiol. 2007 Sep;28(9):1047-53 - PubMed
- JAMA. 2007 Oct 17;298(15):1763-71 - PubMed
- Clin Infect Dis. 2008 Mar 15;46(6):799-806 - PubMed
- Clin Infect Dis. 2008 Mar 15;46(6):787-94 - PubMed
- Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011 - PubMed
- J Clin Microbiol. 2009 Mar;47(3):590-5 - PubMed
- PLoS One. 2009 Aug 04;4(8):e6512 - PubMed
- Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73 - PubMed
- Int J Antimicrob Agents. 2010 Jul;36(1):28-32 - PubMed
- J Assoc Physicians India. 2010 Dec;58 Suppl:25-31 - PubMed
- J Assoc Physicians India. 2010 Dec;58 Suppl:37-40 - PubMed
- Int J Antimicrob Agents. 2011 Oct;38(4):331-5 - PubMed
- ISRN Dermatol. 2012;2012:248951 - PubMed
- PLoS One. 2013;8(1):e52722 - PubMed
- Indian J Med Res. 2013 Feb;137(2):363-9 - PubMed
- Int J Infect Dis. 2013 Nov;17(11):e1051-5 - PubMed
- Scientifica (Cairo). 2014;2014:479048 - PubMed
- J Lab Physicians. 2017 Oct-Dec;9(4):264-268 - PubMed
- J Lab Physicians. 2017 Oct-Dec;9(4):317-321 - PubMed
- J Family Med Prim Care. 2018 Jan-Feb;7(1):162-166 - PubMed
Publication Types